Antitoxic sera were produced in rabbits, goats, and ponies with purified exotoxin A of Pseudomonas aeruginosa (strain PA-l03). None of these sera contained agglutinating antibody against the bacterial cells, and all antitoxins appeared in the IgG fraction. Antitoxic titers of pony sera tended to be higher than those obtained with other animals, and 1 ml of these sera neutralized as much as a 5,000 mouse LD50 dose of toxin. The antitoxic sera, when given in sufficient quantity, could prevent the lethal effects of infection caused by strains of P. aeru-ginosa whose somatic antigens were unrelated to those of strain PA-I03, provided the serotype of the exotoxin produced by the organisms was identical. Antitoxin A did not neutralize the cell-bo...
One of the major virulence factors f Pseudomonas aeruginosa is a protein exotoxin termed toxin A [1-...
The exotoxin A gene (toxA) from Pseudomonas aeruginosa PAO1 was expressed from the lac promoter in E...
Aim. Evaluation of the efficacy and safety of the three experimental lots of Recombinant Pseudomonas...
Several cellular and subcellular fractions were prepared from Pseudomonas aeruginosa strain PA-7. Th...
Several cellular and subcellular fractions were prepared from Pseudomonas aeruginosa strain PA-7. Th...
Pseudomonas aeruginosa produces a large number of extracellular toxins, which include phytotoxic fac...
Five strains of Pseudomonas aeruginosa differing in their production of various virulence factors we...
Five strains of Pseudomonas aeruginosa differing in their production of various virulence factors we...
The histopathology and serum enzyme levels of mice inoculated intravenously with Pseudomonas aerugin...
Summary. The effects of exotoxin A (EXA) from Pseudomonas aeruginosa on polymorpho-nuclear leucocyte...
Pseudomonas aeruginosa is an opportunistic pathogen which infect immunocompromised patients. bacteri...
Mice lethality bioassay revealed that out of 102 proteolytic cell-free cultures of Pseudomonas aerug...
THE high levels of antibiotic resistance that occur in Pseudomonas aeruginosa have led to growing in...
Alginate from Pseudomonas aeruginosa 3064 was depolymerized by controlled heating in dilute acid. Th...
Introduction: Pseudomonas aeruginosa, as an opportunistic microorganism, is a major cause of nosocom...
One of the major virulence factors f Pseudomonas aeruginosa is a protein exotoxin termed toxin A [1-...
The exotoxin A gene (toxA) from Pseudomonas aeruginosa PAO1 was expressed from the lac promoter in E...
Aim. Evaluation of the efficacy and safety of the three experimental lots of Recombinant Pseudomonas...
Several cellular and subcellular fractions were prepared from Pseudomonas aeruginosa strain PA-7. Th...
Several cellular and subcellular fractions were prepared from Pseudomonas aeruginosa strain PA-7. Th...
Pseudomonas aeruginosa produces a large number of extracellular toxins, which include phytotoxic fac...
Five strains of Pseudomonas aeruginosa differing in their production of various virulence factors we...
Five strains of Pseudomonas aeruginosa differing in their production of various virulence factors we...
The histopathology and serum enzyme levels of mice inoculated intravenously with Pseudomonas aerugin...
Summary. The effects of exotoxin A (EXA) from Pseudomonas aeruginosa on polymorpho-nuclear leucocyte...
Pseudomonas aeruginosa is an opportunistic pathogen which infect immunocompromised patients. bacteri...
Mice lethality bioassay revealed that out of 102 proteolytic cell-free cultures of Pseudomonas aerug...
THE high levels of antibiotic resistance that occur in Pseudomonas aeruginosa have led to growing in...
Alginate from Pseudomonas aeruginosa 3064 was depolymerized by controlled heating in dilute acid. Th...
Introduction: Pseudomonas aeruginosa, as an opportunistic microorganism, is a major cause of nosocom...
One of the major virulence factors f Pseudomonas aeruginosa is a protein exotoxin termed toxin A [1-...
The exotoxin A gene (toxA) from Pseudomonas aeruginosa PAO1 was expressed from the lac promoter in E...
Aim. Evaluation of the efficacy and safety of the three experimental lots of Recombinant Pseudomonas...